Treatment of Symptoms After Stent Placement for Urinary Tract Obstruction
Status:
Completed
Trial end date:
2018-03-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether combination therapy with Tolterodine ER and
Tamsulosin is more effective than monotherapy with tamsulosin alone in reducing stent
symptoms. The second purpose is to determine if people have less stent discomfort if they
take these medications starting 2 weeks before the stent is placed
The investigators hope to show that the addition of Tolterodine ER to Tamsulosin will provide
added benefits in reducing stent symptoms in patients who have had unilateral placement of a
ureteral stent.